Generalized vitiligo after lymphocyte infusion for relapsed leukaemia

被引:20
作者
Au, WY [1 ]
Yeung, CK [1 ]
Chan, HH [1 ]
Lie, AK [1 ]
机构
[1] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
关键词
bone marrow transplantation; donor lymphocyte infusion; leucotrichia; leukaemia; melanocytes; vitiligo;
D O I
10.1046/j.1365-2133.2001.04500.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Vitiligo is an autoimmune disease caused by T-lymphocyte-mediated destruction of melanocytes. We describe two patients with generalized vitiligo caused iatrogenically after donor lymphocyte infusion (DLI) for leukaemia relapse over 3 years after bone marrow transplantation (BMT). Neither the sibling donor nor the recipient had vitiligo or other autoimmune diseases, and vitiligo did not occur after the first BMT. DLI was accompanied by skin graft-versus-host disease in both cases, which was controlled with immunosuppression. However, over several months, progressive generalized and persistent skin depigmentation occurred in both patients. Peripheral blood molecular studies showed the complete disappearance of host haematolymphopoiesis. The specific destruction of melanocytes in both patients was therefore probably mediated by new alloreactive lymphocytes infused from the donors.
引用
收藏
页码:1015 / 1017
页数:3
相关论文
共 22 条
[1]   Isolated extramedullary relapse of acute lymphoblastic leukaemia after allogeneic bone marrow transplantation [J].
Au, WY ;
Lie, AKW ;
Liang, R ;
Kwong, YL .
BONE MARROW TRANSPLANTATION, 1999, 24 (10) :1137-1140
[2]   Therapy-related myelodysplastic syndrome of recipient origin after allogeneic bone marrow transplantation for acute lymphoblastic leukaemia [J].
Au, WY ;
Lie, AKW ;
Ma, SK ;
Leung, YH ;
Siu, LLP ;
Kwong, YL .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (02) :424-426
[3]   Extensive vitiligo after ganciclovir treatment of GvHD in a patient who had received donor T cells expressing herpes simplex virus thymidine kinase [J].
Aubin, F ;
Cahn, JY ;
Ferrand, C ;
Angonin, R ;
Humbert, P ;
Tiberghien, P .
LANCET, 2000, 355 (9204) :626-627
[4]  
AUSTIN LM, 1995, AM J PATHOL, V146, P1529
[5]   Pathophysiology of vitiligo [J].
Castanet, J ;
Ortonne, JP .
CLINICS IN DERMATOLOGY, 1997, 15 (06) :845-851
[6]  
CHIU EKW, 1995, BONE MARROW TRANSPL, V15, P543
[7]   Lymphocyte populations in dermal lymphoid aggregates of vitiliginous Smyth line and normally pigmented Light Brown Leghorn chickens [J].
Erf, GF ;
Trejo-Skalli, AV ;
Poulin, M ;
Smyth, JR .
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1997, 58 (3-4) :335-343
[8]   ADOPTIVE IMMUNOTHERAPY WITH TUMOR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2 IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA AND RENAL-CELL CARCINOMA - A PILOT-STUDY [J].
GOEDEGEBUURE, PS ;
DOUVILLE, LM ;
LI, H ;
RICHMOND, GC ;
SCHOOF, DD ;
SCAVONE, M ;
EBERLEIN, TJ .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) :1939-1949
[9]  
Handa Sanjeev, 1999, Journal of Dermatology (Tokyo), V26, P653
[10]   Graft-versus-host reactions in dermatology [J].
Johnsen, ML ;
Farmer, ER .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 38 (03) :369-392